Extended Induction Chemotherapy Does Not Improve the Outcome for High-Risk Neuroblastoma Patients: Results of the Randomized Open-Label GPOH Trial NB2004-HR
Annals of Oncology - United Kingdom
doi 10.1016/j.annonc.2019.11.011
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Elsevier BV